miltefosine has been researched along with Experimental Leukemia in 1 studies
miltefosine: hexadecyl phosphocholine derivative of cisplatin; did not substantially activate HIV long terminal repeat; less toxic than cisplatin
miltefosine : A phospholipid that is the hexadecyl monoester of phosphocholine.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wang, YZ | 1 |
| Liu, XY | 1 |
| Wu, LJ | 1 |
| Zhang, YB | 1 |
| Hou, L | 1 |
| Xu, QS | 1 |
1 other study available for miltefosine and Experimental Leukemia
| Article | Year |
|---|---|
Antiproliferation effects of hexadecylphosphocholine on solid tumour and leukaemia selectively in vitro.
Topics: Animals; Antineoplastic Agents; Cell Division; Dose-Response Relationship, Drug; Leukemia, Experimen | 1997 |